Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Neamati

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry|June 27, 2001
Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integraseX Zhang, N Neamati, Y K Lee, et al.
Journal of Medicinal Chemistry|January 17, 1997
Coumarin-based inhibitors of HIV integraseH Zhao, N Neamati, H Hong, et al.
Journal of Medicinal Chemistry|March 14, 1997
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searchingN Neamati, H Hong, A Mazumder, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Identification of a nucleotide binding site in HIV-1 integraseR R Drake, N Neamati, H Hong, et al.
Journal of Medicinal Chemistry|March 14, 1997
Discovery of HIV-1 integrase inhibitors by pharmacophore searchingH Hong, N Neamati, S Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitorJ Lubkowski, F Yang, J Alexandratos, et al.
Bioorganic & Medicinal Chemistry|November 1, 2000
Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targetsI J Chen, N Neamati, M C Nicklaus, et al.
Journal of Medicinal Chemistry|June 21, 1996
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and proteaseA Mazumder, S Wang, N Neamati, et al.
Molecular Pharmacology|August 23, 2000
Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl estersW Pluymers, N Neamati, C Pannecouque, et al.
Journal of Medicinal Chemistry|August 14, 1998
Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active siteN Neamati, H Hong, J M Owen, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|June 27, 2001
Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integraseX Zhang, N Neamati, Y K Lee, et al.
Journal of Medicinal Chemistry|January 17, 1997
Coumarin-based inhibitors of HIV integraseH Zhao, N Neamati, H Hong, et al.
Journal of Medicinal Chemistry|March 14, 1997
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searchingN Neamati, H Hong, A Mazumder, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Identification of a nucleotide binding site in HIV-1 integraseR R Drake, N Neamati, H Hong, et al.
Journal of Medicinal Chemistry|March 14, 1997
Discovery of HIV-1 integrase inhibitors by pharmacophore searchingH Hong, N Neamati, S Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitorJ Lubkowski, F Yang, J Alexandratos, et al.
Bioorganic & Medicinal Chemistry|November 1, 2000
Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targetsI J Chen, N Neamati, M C Nicklaus, et al.
Journal of Medicinal Chemistry|June 21, 1996
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and proteaseA Mazumder, S Wang, N Neamati, et al.
Molecular Pharmacology|August 23, 2000
Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl estersW Pluymers, N Neamati, C Pannecouque, et al.
Journal of Medicinal Chemistry|August 14, 1998
Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active siteN Neamati, H Hong, J M Owen, et al.
Pageof 5